MMC (TMZ) -TOC (TFA)

• Description:

  MMC (TMZ) -TOC TFA has high binding affinity and selectivity for somatostatin receptor subtype-2 (SSTR2) . MMC (TMZ) -TOC TFA targets delivery of TMZ to SSTR2-positive tumor cells. MMC (TMZ) -TOC TFA can be used for the research of cancer[1].

• UNSPSC:

  12352005

• Target:

  Somatostatin Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Field of Research:

  Cancer

• Purity:

  95.64

• Smiles:

  OC(CN1CCN(CC(N[C@H](CC2=CC=CC=C2)C(N[C@@H](CSSC[C@H](NC([C@@]([C@@H](C)O)([H])NC3=O)=O)C(N[C@@H]([C@@H](C)O)CO)=O)C(N[C@@H](CC4=CC=C(O)C=C4)C(N[C@@H](C(N[C@H]3CCCCN)=O)CC5=CC6=C(N5)C=CC=C6)=O)=O)=O)=O)CCN(CC(O)=O)CCN(C(CCNC(C7=C(N8C=N7)N=NN(C)C8=O)=O)=O)CC1)=O.OC(C(F)(F)F)=O

• Molecular Formula:

  C74H99F3N20O21S2

• Molecular Weight:

  1725.82

• References & Citations:

  [1]AghaAmiri S, et al. Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide. J Med Chem. 2024 Feb 22;67 (4) :2425-2437.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported